HPV primary cervical screening: Time for a change

Cytopathology

Volumn 26, Issue 1, 2015, Pages 4-6

  Kitchener, H C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CARCINOGENESIS; CERVICAL SCREENING; COLPOSCOPY; EDITORIAL; GYNECOLOGICAL EXAMINATION; HUMAN; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VACCINATION; VIRAL CLEARANCE; WART VIRUS; ADULT; CYTODIAGNOSIS; FEMALE; GREAT BRITAIN; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOGENICITY; VAGINA SMEAR; VIROLOGY;

ADULT; CYTODIAGNOSIS; FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS;

EID: 84922653308     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12236     Document Type: Editorial

References (12)

1. Cancer Research UK. Cervical cancer mortality statistics. 2013. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/mortality/.
2. Moss SM, Bailey A, Cubie H et al. Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme. Cytopathology 2014; DOI:10.1111/cyt12210 [Epub date Oct 2, 2014].
3. Bulkmans NW, Berkhof J, Rozendaal L et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-72.
4. Kitchener HC, Almonte M, Thomson C et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009;10:672-82.
5. Naucler P, Ryd W, Tornberg S et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357:1589-97.
6. Ronco G, Giorgi-Rossi P, Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57.
7. Ronco G, Dillner J, Elfstrom KM et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524-32.
8. Kitchener HC, Almonte M, Gilham C et al. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess 2009;13:1-150, iii-iv.
9. Kitchener HC, Gilham C, Sargent A et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 2011;47:864-71.
10. Kelly RS, Patnick J, Kitchener HC, Moss SM. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer 2011;105:983-8.
11. Kitchener HC, Canfell K, Gilham C et al. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. Health Technol Assess 2014;18(23).
12. Paavonen J, Naud P, Salmeron J et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.